Aurinia Will Attend 2024 Jefferies Global Healthcare Conference

About this update from Aurinia Pharmaceuticals Inc

ROCKVILLE, Md. & EDMONTON, Alberta --(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Jefferies Global Healthcare Conference in New York from June 4-6, 2024 . Aurinia management will host one-on-one meetings with investors and will participate in a presentation on Wednesday, June 5 , from 8:00 to 8:25 AM Eastern Time . A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here. About Aurinia Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021 , the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta , its U.S. commercial office is in Rockville, Maryland . The Company focuses its development efforts globally. View source version on businesswire.com : https://www.businesswire.com/news/home/20240530835927/en/ Media and Investor Inquiries: Andrea Christopher Corporate Communications and Investor Relations, Aurinia [email protected] [email protected] Source: Aurinia Pharmaceuticals Inc.

View stock analysis, news, and events for Aurinia Pharmaceuticals Inc